QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Pliant Therapeutics (PLRX) Earnings Date, Estimates & Call Transcripts

$16.62
-0.59 (-3.43%)
(As of 02/28/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

PLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PLRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pliant Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.80)($0.73)($0.77)
Q2 20242($0.85)($0.74)($0.80)
Q3 20242($0.87)($0.75)($0.81)
Q4 20242($0.86)($0.76)($0.81)
FY 20248($3.38)($2.98)($3.18)

PLRX Earnings Date and Information

Pliant Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates.

Pliant Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/14/2024
Estimated)
------- 
11/9/2023Q3 2023($0.78)($0.70)+$0.08($0.70)--
8/9/2023Q2 2023($0.73)($0.70)+$0.03($0.70)$1.10 million$0.25 million
5/9/2023Q1 2023($0.66)($0.67)($0.01)($0.67)$1.96 million$1.33 million
3/9/2023Q4 2022($0.70)($0.72)($0.02)($0.72)$1.55 million$1.97 million
11/8/2022Q3 2022($0.74)($0.65)+$0.09($0.65)$2.26 million$1.48 million
8/8/2022Q2 2022($0.82)($0.82)-($0.82)$1.35 million$4.99 million
5/9/2022Q1 2022($0.77)($0.78)($0.01)($0.78)$1.43 million$1.25 million
2/28/2022Q4 2021($0.76)($0.68)+$0.08($0.68)$3.70 million$2.00 million
11/9/2021Q3 2021($0.69)($0.75)($0.06)($0.75)$2.50 million$1.61 million
8/9/2021Q2 2021($0.67)($0.64)+$0.03($0.64)-$1.79 million
5/10/2021Q1 2021($0.60)($0.64)($0.04)($0.64)-$2.17 million
3/15/2021Q4 2020($0.71)($0.54)+$0.17($0.54)$2.60 million$4.47 million












Pliant Therapeutics Earnings - Frequently Asked Questions

When is Pliant Therapeutics's earnings date?

Pliant Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off last year's report dates. Learn more on PLRX's earnings history.

How much revenue does Pliant Therapeutics generate each year?

Pliant Therapeutics (NASDAQ:PLRX) has a recorded annual revenue of $9.69 million.

How much profit does Pliant Therapeutics generate each year?

Pliant Therapeutics (NASDAQ:PLRX) has a recorded net income of -$123.32 million. PLRX has generated -$2.79 earnings per share over the last four quarters.

What is Pliant Therapeutics's EPS forecast for next year?

Pliant Therapeutics's earnings are expected to decrease from ($2.89) per share to ($3.51) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:PLRX) was last updated on 2/28/2024 by MarketBeat.com Staff